Eli Lilly - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Lilly’s Taltz meets primary goal in Phase IV plaque psoriasis trial

Eli Lilly
Lilly’s Taltz meets Phase IV trial’s primary endpoint in patients with moderate to severe plaque psoriasis. Credit: Momoneymoproblemz.